{
  "document_id": "HOUSE_OVERSIGHT_024766",
  "filename": "IMAGES-008-HOUSE_OVERSIGHT_024766.txt",
  "text": "ACKRELL\nCAPITAL\n\nCannabis Investment Report | December 2017\n\nToronto Stock Exchange\n\n($U.S. millions, except stock price)\n\nLTM Forward Forward\nEV Revenue EBITDA\nStock % Below . : .\n\nPrice 52-Week Market Enterprise LTM LTM Multiples __Muttiples Multiples\nCompany Ticker 11/30/17 High Value  Value(EV) Revenue EBITDA Revenue EBITDA 2018 2019 2018 2019\nAphria Inc. TSX:APH $8.91 9.9%  $1,350.2 $1,281.7 $17.7 $3.8 724x NM 37.7x 9.9x NM 27.5x\nAurora Cannabis Inc. TSX:ACB 6.21 7.6% 2,483.5 2,406.8 18.6 -47 NM NM 48.6 13.6 NM 30.4\nCanniMed Therapeutics Inc. | TSX:CMED 15:15 10.9% 347.8 315.8 12.0 2.0 26.3 NM 10.6 54  48.5x 13.3\nCanopy Growth Corporation  TSX:WEED 14.30 15.1% 2,720.6 2,641.7 46.3 19 57.1 NM 39.7 11.7 NM NM\nMedReleaf Corp. TSX:LEAF 12.66 13.7% 1,146.2 1,094.8 32.9 97 S615 NM 30.8 9.4 NM 27.0\nNeptune Technologies 8 TS y.NEPT 154 16.0% 120.8 127.4 324 37 3.9 NM 6.0 43 NM NM\n\nBioressources Inc.\n\nMedian 12.3%  $1,248.2 $1,188.3 -$0.1 33.3x\n\nTSX Venture Exchange\n\n($U.S. millions, except stock price)\n\nLTM Forward Forward\nStock  %Below EV Revenue EBITDA\nPrice 52-Week Market Enterprise LTM LTM Multiples Multiples —Mittiples\n\nCompany Ticker 11/30/17 High Value  Value(EV) Revenue EBITDA Revenue EBITDA _ 2018 _2019 2018 2019\nABcann Global Corporation SXV:ABCN $1.13 19.9% $152.7 $129.7 $0.7 -$8.7 NM NM 11.2x 2.6% NM 9.2x\nCannabis Wheaton Income SXV:CBW 0.68 56.5% 157.2 157.0 01 -6.2 NM NM NA NA NA NA\nCronos Group Inc. SXV:MJN 3.38 9.0% 503.2 494.0 23. 25 NM NM 16.1 5.8 NM 17.6\nDelta 9 Cannabis Inc. SXV:NINE 2.37 23.8% 143.9 145.5 04 -17 NM NM NA NA NA NA\nEmblem Corp. SXV:EMC 1.26 64.6% 117.1 108.0 1.8 -75 59.4x NM 10.5 2.0 NA 5.6\nEmerald Health Therapeutics TSXV:EMH 2.27 4.6% 213.8 195.6 0.6 -43 NM NM 46.6 NA NA NA\nHarvest One Cannabis Inc. SXV:HVST 0.71 18.6% 63.7 54.1 0.2 -45 NM NM 17.0 18 NA 9.2\nHempco Food and Fiber Inc. TSXV:HEMP 1.66 31.6% 15 774 47 -1.3 16.5 NM NA NA NA NA\nCC International Cannabis SXV:ICC 0.76 44.3% 104.6 102.5 01 -45 NM NM 64 14 NM 4.0\nnvictus MD Strategies Corp. TSXV:IMH 142 33.6% 89.6 66.7 1.8 -10.3 37.6 NM 213 3.6 NM 13.3\nLGC Capital Ltd. SXV:LG 0.29 24.0% 79.6 76.6 0.0 -17 NM NM NA NA NA NA\nMaple Leaf Green World Inc. TSXV:MGW 0.46 24.4% 67.3 64.2 04 -14 NM NM NA NA NA NA\nNational Access Clinic Corp. © TSXV:NAC 0.40 30.1% 24.0 25.0 07 -2.4 36.7 NM NA NA NA NA\nNaturally Splendid Enter. SXV:NSP 0.21 45.0% 20.4 20.9 19 -43 10.9 NM NA NA NA NA\nNewstrike Resources Ltd. SXV:HIP 0.39 16.7% 151.1 152.1 0.0 -0.3 NM NM NA NA NA NA\nOrganiGram Holdings Inc. SXV:0GI 2.61 15.7% 2774 244.2 40 -5.2 60.7 NM 97 34 46.5x 12.6\nTetra Bio-Pharma Inc. SXV:TBP 0.54 14.8% 63.6 62.0 0.0 -3.9 NM NM NA NA NA NA\nThe Hydrapothecary Corp. SXV:THCX 192 17.7% 149.8 168.3 3.3 -0.6 40.7 NM 15.8 3.6 NM 29.8\nViridium Pacific Group Ltd. SXVVIR 1.09 15.2% 49.5 48.6 0.0 -0.1 NM NM NA NA NA NA\nWeedMD Inc. SXV:WMD 1.69 12.8% 123.2 121.0 0.5 -3.1 NM NM oto) 23 NM 8.6\n\n21.8% $110.8 $105.3\n\nSource: S&P Global Market Intelligence. Not Meaningful (NM) used for negative multiples, and for revenue multiples greater than 100.0x and\nEBITDA multiples greater than 50.0x. Not Available (NA) used for information that is not available. Enterprise Value is defined as Market Value\nplus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation\nand Amortization.\n\n130 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC\n\nHOUSE_OVERSIGHT_024766",
  "metadata": {
    "original_filename": "IMAGES-008-HOUSE_OVERSIGHT_024766.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 3436,
    "word_count": 601,
    "line_count": 66,
    "import_date": "2025-11-19T21:47:45.181932",
    "prefix": "IMAGES-008"
  }
}